Current Ratio
Higher than 50% of Healthcare sector peers
Updated 438h ago
Sector Performance
50th percentileRARE
2.02x
Sector Median
2.02x
Sector Avg
3.77x
Deep Analysis
The current ratio of 2.02x means Ultragenyx has $2.02 in current assets for every $1 of current liabilities, indicating it can cover short-term obligations with room to spare.
This equals the healthcare sector median of exactly 2.02x, placing the company at the 50th percentile among its peers. Because only one historical data point is available, the year-over-year change is N/A, the quarter-over-quarter change is N/A, and no trend direction can be assessed over the last eight quarters. With a level precisely at the sector average and no trend to evaluate, the metric offers neither an additional risk nor a clear opportunity from a liquidity perspective. This neutral positioning is consistent with the overall CAUTIOUS verdict, as the current ratio alone does not contradict the cautious view—it simply provides no strong supportive or negative signal.
Frequently Asked Questions
What does the Current Ratio tell investors about RARE?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
How does RARE's Current Ratio compare to its sector?
RARE's Current Ratio of 2.02x compares to a Healthcare sector median of 2.02x, placing it in the 50th percentile.
Who are RARE's closest peers by Current Ratio?
The closest Healthcare peers by Current Ratio include: A (2.10x), BSX (1.90x), EXAS (2.23x), TMO (1.53x), ALGN (1.39x).
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master RARE's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RARE research report →RARE
2.02x
Sector Median
2.02x
Sector Avg
3.77x
How RARE's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.